調査レポート | • レポートコード：GIR-2104Z05217 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、勃起不全のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。勃起不全の種類別市場規模（ED治療薬、ED用機械）、用途別市場規模（先天性患者、病理学的患者）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・勃起不全の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Eli Lilly、Pfizer、Bayer、Boston Scientific、Coloplast、Apricus Biosciences、Cristalia Produtos Quimicos Farmaceuticos、Dong-A Socio、Endo Pharmaceuticals、Futura Medical、Meda Pharmaceuticals、Promedon、SK Chemical、Teva Pharmaceuticals、Vivus、Zephyr Surgical Implants (ZSI) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ED治療薬、ED用機械 ・用途別分析2016年-2026年：先天性患者、病理学的患者 ・勃起不全の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・勃起不全のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・勃起不全のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・勃起不全の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・勃起不全の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Erectile Dysfunction market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Erectile Dysfunction size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Erectile Dysfunction market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Erectile Dysfunction market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
ED Drugs
ED Devices
Market segment by Application, can be divided into
Congenital Patients
Pathological Patients
Market segment by players, this report covers
Eli Lilly
Pfizer
Bayer
Boston Scientific
Coloplast
Apricus Biosciences
Cristalia Produtos Quimicos Farmaceuticos
Dong-A Socio
Endo Pharmaceuticals
Futura Medical
Meda Pharmaceuticals
Promedon
SK Chemical
Teva Pharmaceuticals
Vivus
Zephyr Surgical Implants (ZSI)
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Erectile Dysfunction
1.2 Classification of Erectile Dysfunction by Type
1.2.1 Overview: Global Erectile Dysfunction Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Erectile Dysfunction Revenue Market Share by Type in 2020
1.2.3 ED Drugs
1.2.4 ED Devices
1.3 Global Erectile Dysfunction Market by Application
1.3.1 Overview: Global Erectile Dysfunction Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Congenital Patients
1.3.3 Pathological Patients
1.4 Global Erectile Dysfunction Market Size & Forecast
1.5 Global Erectile Dysfunction Market Size and Forecast by Region
1.5.1 Global Erectile Dysfunction Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Erectile Dysfunction Market Size by Region, (2016-2021)
1.5.3 North America Erectile Dysfunction Market Size and Prospect (2016-2026)
1.5.4 Europe Erectile Dysfunction Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Erectile Dysfunction Market Size and Prospect (2016-2026)
1.5.6 South America Erectile Dysfunction Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Erectile Dysfunction Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Erectile Dysfunction Market Drivers
1.6.2 Erectile Dysfunction Market Restraints
1.6.3 Erectile Dysfunction Trends Analysis
2 Company Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business
2.1.3 Eli Lilly Erectile Dysfunction Product and Solutions
2.1.4 Eli Lilly Erectile Dysfunction Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Eli Lilly Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Erectile Dysfunction Product and Solutions
2.2.4 Pfizer Erectile Dysfunction Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Erectile Dysfunction Product and Solutions
2.3.4 Bayer Erectile Dysfunction Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bayer Recent Developments and Future Plans
2.4 Boston Scientific
2.4.1 Boston Scientific Details
2.4.2 Boston Scientific Major Business
2.4.3 Boston Scientific Erectile Dysfunction Product and Solutions
2.4.4 Boston Scientific Erectile Dysfunction Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Boston Scientific Recent Developments and Future Plans
2.5 Coloplast
2.5.1 Coloplast Details
2.5.2 Coloplast Major Business
2.5.3 Coloplast Erectile Dysfunction Product and Solutions
2.5.4 Coloplast Erectile Dysfunction Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Coloplast Recent Developments and Future Plans
2.6 Apricus Biosciences
2.6.1 Apricus Biosciences Details
2.6.2 Apricus Biosciences Major Business
2.6.3 Apricus Biosciences Erectile Dysfunction Product and Solutions
2.6.4 Apricus Biosciences Erectile Dysfunction Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Apricus Biosciences Recent Developments and Future Plans
2.7 Cristalia Produtos Quimicos Farmaceuticos
2.7.1 Cristalia Produtos Quimicos Farmaceuticos Details
2.7.2 Cristalia Produtos Quimicos Farmaceuticos Major Business
2.7.3 Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Product and Solutions
2.7.4 Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Cristalia Produtos Quimicos Farmaceuticos Recent Developments and Future Plans
2.8 Dong-A Socio
2.8.1 Dong-A Socio Details
2.8.2 Dong-A Socio Major Business
2.8.3 Dong-A Socio Erectile Dysfunction Product and Solutions
2.8.4 Dong-A Socio Erectile Dysfunction Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Dong-A Socio Recent Developments and Future Plans
2.9 Endo Pharmaceuticals
2.9.1 Endo Pharmaceuticals Details
2.9.2 Endo Pharmaceuticals Major Business
2.9.3 Endo Pharmaceuticals Erectile Dysfunction Product and Solutions
2.9.4 Endo Pharmaceuticals Erectile Dysfunction Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Endo Pharmaceuticals Recent Developments and Future Plans
2.10 Futura Medical
2.10.1 Futura Medical Details
2.10.2 Futura Medical Major Business
2.10.3 Futura Medical Erectile Dysfunction Product and Solutions
2.10.4 Futura Medical Erectile Dysfunction Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Futura Medical Recent Developments and Future Plans
2.11 Meda Pharmaceuticals
2.11.1 Meda Pharmaceuticals Details
2.11.2 Meda Pharmaceuticals Major Business
2.11.3 Meda Pharmaceuticals Erectile Dysfunction Product and Solutions
2.11.4 Meda Pharmaceuticals Erectile Dysfunction Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Meda Pharmaceuticals Recent Developments and Future Plans
2.12 Promedon
2.12.1 Promedon Details
2.12.2 Promedon Major Business
2.12.3 Promedon Erectile Dysfunction Product and Solutions
2.12.4 Promedon Erectile Dysfunction Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Promedon Recent Developments and Future Plans
2.13 SK Chemical
2.13.1 SK Chemical Details
2.13.2 SK Chemical Major Business
2.13.3 SK Chemical Erectile Dysfunction Product and Solutions
2.13.4 SK Chemical Erectile Dysfunction Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 SK Chemical Recent Developments and Future Plans
2.14 Teva Pharmaceuticals
2.14.1 Teva Pharmaceuticals Details
2.14.2 Teva Pharmaceuticals Major Business
2.14.3 Teva Pharmaceuticals Erectile Dysfunction Product and Solutions
2.14.4 Teva Pharmaceuticals Erectile Dysfunction Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Teva Pharmaceuticals Recent Developments and Future Plans
2.15 Vivus
2.15.1 Vivus Details
2.15.2 Vivus Major Business
2.15.3 Vivus Erectile Dysfunction Product and Solutions
2.15.4 Vivus Erectile Dysfunction Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Vivus Recent Developments and Future Plans
2.16 Zephyr Surgical Implants (ZSI)
2.16.1 Zephyr Surgical Implants (ZSI) Details
2.16.2 Zephyr Surgical Implants (ZSI) Major Business
2.16.3 Zephyr Surgical Implants (ZSI) Erectile Dysfunction Product and Solutions
2.16.4 Zephyr Surgical Implants (ZSI) Erectile Dysfunction Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Zephyr Surgical Implants (ZSI) Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Erectile Dysfunction Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Erectile Dysfunction Players Market Share
3.2.2 Top 10 Erectile Dysfunction Players Market Share
3.2.3 Market Competition Trend
3.3 Erectile Dysfunction Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Erectile Dysfunction Revenue and Market Share by Type (2016-2021)
4.2 Global Erectile Dysfunction Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Erectile Dysfunction Revenue Market Share by Application (2016-2021)
5.2 Erectile Dysfunction Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Erectile Dysfunction Revenue by Type (2016-2026)
6.2 North America Erectile Dysfunction Revenue by Application (2016-2026)
6.3 North America Erectile Dysfunction Market Size by Country
6.3.1 North America Erectile Dysfunction Revenue by Country (2016-2026)
6.3.2 United States Erectile Dysfunction Market Size and Forecast (2016-2026)
6.3.3 Canada Erectile Dysfunction Market Size and Forecast (2016-2026)
6.3.4 Mexico Erectile Dysfunction Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Erectile Dysfunction Revenue by Type (2016-2026)
7.2 Europe Erectile Dysfunction Revenue by Application (2016-2026)
7.3 Europe Erectile Dysfunction Market Size by Country
7.3.1 Europe Erectile Dysfunction Revenue by Country (2016-2026)
7.3.2 Germany Erectile Dysfunction Market Size and Forecast (2016-2026)
7.3.3 France Erectile Dysfunction Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Erectile Dysfunction Market Size and Forecast (2016-2026)
7.3.5 Russia Erectile Dysfunction Market Size and Forecast (2016-2026)
7.3.6 Italy Erectile Dysfunction Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Erectile Dysfunction Revenue by Type (2016-2026)
8.2 Asia-Pacific Erectile Dysfunction Revenue by Application (2016-2026)
8.3 Asia-Pacific Erectile Dysfunction Market Size by Region
8.3.1 Asia-Pacific Erectile Dysfunction Revenue by Region (2016-2026)
8.3.2 China Erectile Dysfunction Market Size and Forecast (2016-2026)
8.3.3 Japan Erectile Dysfunction Market Size and Forecast (2016-2026)
8.3.4 South Korea Erectile Dysfunction Market Size and Forecast (2016-2026)
8.3.5 India Erectile Dysfunction Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Erectile Dysfunction Market Size and Forecast (2016-2026)
8.3.7 Australia Erectile Dysfunction Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Erectile Dysfunction Revenue by Type (2016-2026)
9.2 South America Erectile Dysfunction Revenue by Application (2016-2026)
9.3 South America Erectile Dysfunction Market Size by Country
9.3.1 South America Erectile Dysfunction Revenue by Country (2016-2026)
9.3.2 Brazil Erectile Dysfunction Market Size and Forecast (2016-2026)
9.3.3 Argentina Erectile Dysfunction Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Erectile Dysfunction Revenue by Type (2016-2026)
10.2 Middle East & Africa Erectile Dysfunction Revenue by Application (2016-2026)
10.3 Middle East & Africa Erectile Dysfunction Market Size by Country
10.3.1 Middle East & Africa Erectile Dysfunction Revenue by Country (2016-2026)
10.3.2 Turkey Erectile Dysfunction Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Erectile Dysfunction Market Size and Forecast (2016-2026)
10.3.4 UAE Erectile Dysfunction Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Erectile Dysfunction Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Erectile Dysfunction Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Erectile Dysfunction Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Erectile Dysfunction Revenue (USD Million) by Region (2016-2021)
Table 5. Global Erectile Dysfunction Revenue Market Share by Region (2021-2026)
Table 6. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 7. Eli Lilly Major Business
Table 8. Eli Lilly Erectile Dysfunction Product and Solutions
Table 9. Eli Lilly Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Pfizer Corporate Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Erectile Dysfunction Product and Solutions
Table 13. Pfizer Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bayer Corporate Information, Head Office, and Major Competitors
Table 15. Bayer Major Business
Table 16. Bayer Erectile Dysfunction Product and Solutions
Table 17. Bayer Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Boston Scientific Corporate Information, Head Office, and Major Competitors
Table 19. Boston Scientific Major Business
Table 20. Boston Scientific Erectile Dysfunction Product and Solutions
Table 21. Boston Scientific Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Coloplast Corporate Information, Head Office, and Major Competitors
Table 23. Coloplast Major Business
Table 24. Coloplast Erectile Dysfunction Product and Solutions
Table 25. Coloplast Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Apricus Biosciences Corporate Information, Head Office, and Major Competitors
Table 27. Apricus Biosciences Major Business
Table 28. Apricus Biosciences Erectile Dysfunction Product and Solutions
Table 29. Apricus Biosciences Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Cristalia Produtos Quimicos Farmaceuticos Corporate Information, Head Office, and Major Competitors
Table 31. Cristalia Produtos Quimicos Farmaceuticos Major Business
Table 32. Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Product and Solutions
Table 33. Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Dong-A Socio Corporate Information, Head Office, and Major Competitors
Table 35. Dong-A Socio Major Business
Table 36. Dong-A Socio Erectile Dysfunction Product and Solutions
Table 37. Dong-A Socio Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Endo Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 39. Endo Pharmaceuticals Major Business
Table 40. Endo Pharmaceuticals Erectile Dysfunction Product and Solutions
Table 41. Endo Pharmaceuticals Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Futura Medical Corporate Information, Head Office, and Major Competitors
Table 43. Futura Medical Major Business
Table 44. Futura Medical Erectile Dysfunction Product and Solutions
Table 45. Futura Medical Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Meda Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 47. Meda Pharmaceuticals Major Business
Table 48. Meda Pharmaceuticals Erectile Dysfunction Product and Solutions
Table 49. Meda Pharmaceuticals Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Promedon Corporate Information, Head Office, and Major Competitors
Table 51. Promedon Major Business
Table 52. Promedon Erectile Dysfunction Product and Solutions
Table 53. Promedon Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. SK Chemical Corporate Information, Head Office, and Major Competitors
Table 55. SK Chemical Major Business
Table 56. SK Chemical Erectile Dysfunction Product and Solutions
Table 57. SK Chemical Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Teva Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 59. Teva Pharmaceuticals Major Business
Table 60. Teva Pharmaceuticals Erectile Dysfunction Product and Solutions
Table 61. Teva Pharmaceuticals Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Vivus Corporate Information, Head Office, and Major Competitors
Table 63. Vivus Major Business
Table 64. Vivus Erectile Dysfunction Product and Solutions
Table 65. Vivus Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Zephyr Surgical Implants (ZSI) Corporate Information, Head Office, and Major Competitors
Table 67. Zephyr Surgical Implants (ZSI) Major Business
Table 68. Zephyr Surgical Implants (ZSI) Erectile Dysfunction Product and Solutions
Table 69. Zephyr Surgical Implants (ZSI) Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Global Erectile Dysfunction Revenue (USD Million) by Players (2019-2021)
Table 71. Global Erectile Dysfunction Revenue Share by Players (2019-2021)
Table 72. Breakdown of Erectile Dysfunction by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Erectile Dysfunction Players Head Office, Products and Services Provided
Table 74. Erectile Dysfunction Mergers & Acquisitions in the Past Five Years
Table 75. Erectile Dysfunction New Entrants and Expansion Plans
Table 76. Global Erectile Dysfunction Revenue (USD Million) by Type (2016-2021)
Table 77. Global Erectile Dysfunction Revenue Share by Type (2016-2021)
Table 78. Global Erectile Dysfunction Revenue Forecast by Type (2021-2026)
Table 79. Global Erectile Dysfunction Revenue by Application (2016-2021)
Table 80. Global Erectile Dysfunction Revenue Forecast by Application (2021-2026)
Table 81. North America Erectile Dysfunction Revenue by Type (2016-2021) & (USD Million)
Table 82. North America Erectile Dysfunction Revenue by Type (2021-2026) & (USD Million)
Table 83. North America Erectile Dysfunction Revenue by Application (2016-2021) & (USD Million)
Table 84. North America Erectile Dysfunction Revenue by Application (2021-2026) & (USD Million)
Table 85. North America Erectile Dysfunction Revenue by Country (2016-2021) & (USD Million)
Table 86. North America Erectile Dysfunction Revenue by Country (2021-2026) & (USD Million)
Table 87. Europe Erectile Dysfunction Revenue by Type (2016-2021) & (USD Million)
Table 88. Europe Erectile Dysfunction Revenue by Type (2021-2026) & (USD Million)
Table 89. Europe Erectile Dysfunction Revenue by Application (2016-2021) & (USD Million)
Table 90. Europe Erectile Dysfunction Revenue by Application (2021-2026) & (USD Million)
Table 91. Europe Erectile Dysfunction Revenue by Country (2016-2021) & (USD Million)
Table 92. Europe Erectile Dysfunction Revenue by Country (2021-2026) & (USD Million)
Table 93. Asia-Pacific Erectile Dysfunction Revenue by Type (2016-2021) & (USD Million)
Table 94. Asia-Pacific Erectile Dysfunction Revenue by Type (2021-2026) & (USD Million)
Table 95. Asia-Pacific Erectile Dysfunction Revenue by Application (2016-2021) & (USD Million)
Table 96. Asia-Pacific Erectile Dysfunction Revenue by Application (2021-2026) & (USD Million)
Table 97. Asia-Pacific Erectile Dysfunction Revenue by Region (2016-2021) & (USD Million)
Table 98. Asia-Pacific Erectile Dysfunction Revenue by Region (2021-2026) & (USD Million)
Table 99. South America Erectile Dysfunction Revenue by Type (2016-2021) & (USD Million)
Table 100. South America Erectile Dysfunction Revenue by Type (2021-2026) & (USD Million)
Table 101. South America Erectile Dysfunction Revenue by Application (2016-2021) & (USD Million)
Table 102. South America Erectile Dysfunction Revenue by Application (2021-2026) & (USD Million)
Table 103. South America Erectile Dysfunction Revenue by Country (2016-2021) & (USD Million)
Table 104. South America Erectile Dysfunction Revenue by Country (2021-2026) & (USD Million)
Table 105. Middle East & Africa Erectile Dysfunction Revenue by Type (2016-2021) & (USD Million)
Table 106. Middle East & Africa Erectile Dysfunction Revenue by Type (2021-2026) & (USD Million)
Table 107. Middle East & Africa Erectile Dysfunction Revenue by Application (2016-2021) & (USD Million)
Table 108. Middle East & Africa Erectile Dysfunction Revenue by Application (2021-2026) & (USD Million)
Table 109. Middle East & Africa Erectile Dysfunction Revenue by Country (2016-2021) & (USD Million)
Table 110. Middle East & Africa Erectile Dysfunction Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Erectile Dysfunction Picture
Figure 2. Global Erectile Dysfunction Revenue Market Share by Type in 2020
Figure 3. ED Drugs
Figure 4. ED Devices
Figure 5. Erectile Dysfunction Revenue Market Share by Application in 2020
Figure 6. Congenital Patients Picture
Figure 7. Pathological Patients Picture
Figure 8. Global Erectile Dysfunction Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Erectile Dysfunction Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Erectile Dysfunction Revenue Market Share by Region (2016-2026)
Figure 11. Global Erectile Dysfunction Revenue Market Share by Region in 2020
Figure 12. North America Erectile Dysfunction Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Erectile Dysfunction Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Erectile Dysfunction Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Erectile Dysfunction Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Erectile Dysfunction Market Drivers
Figure 17. Erectile Dysfunction Market Restraints
Figure 18. Erectile Dysfunction Market Trends
Figure 19. Eli Lilly Recent Developments and Future Plans
Figure 20. Pfizer Recent Developments and Future Plans
Figure 21. Bayer Recent Developments and Future Plans
Figure 22. Boston Scientific Recent Developments and Future Plans
Figure 23. Coloplast Recent Developments and Future Plans
Figure 24. Apricus Biosciences Recent Developments and Future Plans
Figure 25. Cristalia Produtos Quimicos Farmaceuticos Recent Developments and Future Plans
Figure 26. Dong-A Socio Recent Developments and Future Plans
Figure 27. Endo Pharmaceuticals Recent Developments and Future Plans
Figure 28. Futura Medical Recent Developments and Future Plans
Figure 29. Meda Pharmaceuticals Recent Developments and Future Plans
Figure 30. Promedon Recent Developments and Future Plans
Figure 31. SK Chemical Recent Developments and Future Plans
Figure 32. Teva Pharmaceuticals Recent Developments and Future Plans
Figure 33. Vivus Recent Developments and Future Plans
Figure 34. Zephyr Surgical Implants (ZSI) Recent Developments and Future Plans
Figure 36. Global Erectile Dysfunction Revenue Share by Players in 2020
Figure 37. Erectile Dysfunction Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players Erectile Dysfunction Revenue Market Share in 2020
Figure 39. Global Top 10 Players Erectile Dysfunction Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global Erectile Dysfunction Revenue Share by Type in 2020
Figure 42. Global Erectile Dysfunction Market Share Forecast by Type (2021-2026)
Figure 43. Global Erectile Dysfunction Revenue Share by Application in 2020
Figure 44. Global Erectile Dysfunction Market Share Forecast by Application (2021-2026)
Figure 45. North America Erectile Dysfunction Sales Market Share by Type (2016-2026)
Figure 46. North America Erectile Dysfunction Sales Market Share by Application (2016-2026)
Figure 47. North America Erectile Dysfunction Revenue Market Share by Country (2016-2026)
Figure 48. United States Erectile Dysfunction Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada Erectile Dysfunction Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico Erectile Dysfunction Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe Erectile Dysfunction Sales Market Share by Type (2016-2026)
Figure 52. Europe Erectile Dysfunction Sales Market Share by Application (2016-2026)
Figure 53. Europe Erectile Dysfunction Revenue Market Share by Country (2016-2026)
Figure 54. Germany Erectile Dysfunction Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Erectile Dysfunction Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Erectile Dysfunction Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Erectile Dysfunction Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Erectile Dysfunction Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Erectile Dysfunction Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific Erectile Dysfunction Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Erectile Dysfunction Revenue Market Share by Region (2016-2026)
Figure 62. China Erectile Dysfunction Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Erectile Dysfunction Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea Erectile Dysfunction Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Erectile Dysfunction Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Erectile Dysfunction Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Erectile Dysfunction Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Erectile Dysfunction Sales Market Share by Type (2016-2026)
Figure 69. South America Erectile Dysfunction Sales Market Share by Application (2016-2026)
Figure 70. South America Erectile Dysfunction Revenue Market Share by Country (2016-2026)
Figure 71. Brazil Erectile Dysfunction Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina Erectile Dysfunction Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa Erectile Dysfunction Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa Erectile Dysfunction Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa Erectile Dysfunction Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Erectile Dysfunction Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Erectile Dysfunction Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE Erectile Dysfunction Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界の勃起不全市場規模・現状・予測（2021年-2027年） The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels. The ED drugs segment led the market and accounted for almost 80% of the market share in terms of…- 世界の勃起不全用装置市場 2021：企業別、地域別、種類・用途別 The Erectile Dysfunction Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の内皮機能障害市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Endothelial Dysfunction Market The global Endothelial Dysfunction market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the re…
- 世界のmRNA治療市場規模・現状・予測（2021年-2027年） By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for spec…
- 世界のmRNA治療市場規模・現状・予測（2021年-2027年） By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for spec…